| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 12/27/2006 | CN1291997C Method for extracting bacteria mRNA |
| 12/27/2006 | CN1291994C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 12/26/2006 | US7154028 Gibberellin 2-oxidase gene, functions and uses thereof |
| 12/26/2006 | US7154026 Arabidopsis lyases for modulating starch and polysaccharide concentration in plant cells and organs; antisense agents |
| 12/26/2006 | US7153955 Apparatus for use as diagnostic and therapeutic tool in gene therapy |
| 12/26/2006 | US7153954 Biosynthesis of preferential nucleotide sequences; obtain nucleic acid, incubate with cyanoethyl-N,N,N',N'-tetra-substituted phosphoramidite in the presence of a nucleophilic activator, recover adjusted |
| 12/26/2006 | US7153953 Leaf specific gene promoter of coffee |
| 12/26/2006 | US7153952 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 12/26/2006 | US7153951 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives |
| 12/26/2006 | US7153950 For diagnosis of/drugs for inflammatory bowel disease/asthma/ diabetes/arthritis/cirrhosis/skin disorders |
| 12/26/2006 | US7153949 Nucleic acid encoding poly-zinc finger proteins with improved linkers |
| 12/26/2006 | US7153948 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF) |
| 12/26/2006 | US7153947 Ixodes salivary anticomplement protein |
| 12/26/2006 | US7153936 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity |
| 12/26/2006 | US7153827 Produced by recombinant techniques; stimulating angiogenesis for wound healing and for vascular tissue repair |
| 12/26/2006 | US7153685 Mutant estrogen receptors and mutant estrogen response element; wide variety of applications, including gene therapy, in vivo and in vitro expression |
| 12/26/2006 | US7153683 Present invention relates generally to compositions and methods for modulating activity of MAP/ERK kinase MEK3 and/or other MEK family members; is particularly related to polypeptide variants of TAO proteins |
| 12/26/2006 | US7153680 Recombinant watermelon (Citrullus lanatus) hydroperoxide lyase and uses thereof |
| 12/26/2006 | US7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof |
| 12/26/2006 | US7153672 Preparing a cDNA molecule by contacting an RNA molecule, in the presence of dNTPs, with a non-LTR retrotransposon protein or polypeptide having reverse transcriptase, producing a cDNA molecule complementary to the RNA molecule |
| 12/26/2006 | US7153670 Isolated nucleic acid molecule of nucleotides that encode full-length WF-HABP, Hyaluronan-binding protein family |
| 12/26/2006 | US7153668 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disoders |
| 12/26/2006 | US7153667 Discrete acyltransferases associated with type I polyketide synthases and methods of use |
| 12/26/2006 | US7153664 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders |
| 12/26/2006 | US7153663 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from Comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids |
| 12/26/2006 | US7153659 Bioassay for measuring the proliferation of T-cells in Human papiloma virus |
| 12/26/2006 | US7153658 Methods and compositions for detecting targets |
| 12/26/2006 | US7153656 For rapid single/multiple sequence alleles analysis; repeat sequences |
| 12/26/2006 | US7153654 Assay procedure using fluorogenic tracers |
| 12/26/2006 | US7153653 Regulation of gene expression; determining DNA methylation and relation to cell proliferative disorder |
| 12/26/2006 | US7153652 Mismatch repair detection |
| 12/21/2006 | WO2006135786A2 Methods for synthesis of encoded libraries |
| 12/21/2006 | WO2006135400A2 Methods for rapid identification of recombinant organisms |
| 12/21/2006 | WO2006135343A1 Detectable threading intercalator |
| 12/21/2006 | WO2006135263A1 Fibroblast growth factor receptor-5 antibodies and methods for their use |
| 12/21/2006 | WO2006134379A1 Trityl derivatives for enhancing mass spectrometry |
| 12/21/2006 | WO2006134203A1 Compounds for treating or preventing amine oxidase related diseases or disorders |
| 12/21/2006 | WO2006099579A3 Compositions and methods for clonal amplification and analysis of polynucleotides |
| 12/21/2006 | WO2006089268A8 Gene and cognate protein profiles and methods to determine connective tissue markers in normal and pathologic conditions |
| 12/21/2006 | WO2006083852A3 Luca2 and antibodies that bind thereto |
| 12/21/2006 | WO2006080946A3 Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist |
| 12/21/2006 | WO2006078271A3 Cloning and expression of the full length 110 kda antigen of orientia tsutsugamushi to be used as a vaccine component against scrub typhus |
| 12/21/2006 | WO2006060473A3 Methods of treatment of injured or diseased joints with lubricin compositions |
| 12/21/2006 | WO2006033696A3 High density ion transport measurement biochip devices and methods |
| 12/21/2006 | WO2005086835A3 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 12/21/2006 | WO2005086794A3 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor |
| 12/21/2006 | WO2005062967A3 Novel anti-il 13 antibodies and uses thereof |
| 12/21/2006 | WO2005040339A3 Aptamers to human epidermal growth factor receptor-3 |
| 12/21/2006 | WO2004101750A3 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
| 12/21/2006 | WO2004092191A3 Polymeric oligonucleotide prodrugs |
| 12/21/2006 | WO2004078922A3 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 12/21/2006 | WO2003091409A3 Identification of compounds which stimulate bone formation using a cell-based screening assay targeting bmp signaling |
| 12/21/2006 | WO2003054144A3 Human ras interacting protein |
| 12/21/2006 | US20060288452 Expression vector comprising nucleotide sequences coding regulatory sequences associated with ADP-glucose pyrophosphorlyase gene for use as tool in controlled transcription of heterologous protein in plant storage roots |
| 12/21/2006 | US20060288450 Plant N-acylethanolamine binding proteins |
| 12/21/2006 | US20060288448 nucleotide sequence encoding Bacillus thuringiensis Cry8Bb1 protoxin, has at least one proteolytic activation site that has been engineered to comprise a cleavage site that is sensitive to an insect gut cysteine protease; transgenic seed and plant |
| 12/21/2006 | US20060288446 cell comprising an endochitinase, a stilbene synthase and a superoxide dismutase; encoded from a nucleic acid construct which comprises an internal ribosome entry site sequence; confer resistance to sigatoka |
| 12/21/2006 | US20060288441 nucleotide sequence or complements that code polypeptides having synthetase enzyme activity, used to alter enzyme levels in transformed host cells |
| 12/21/2006 | US20060288439 Leaf-specific chlorophyll A/B binding protein promoter |
| 12/21/2006 | US20060288437 Zinc finger-based drug-dependent gene regulation system |
| 12/21/2006 | US20060288434 Inhibiting angiogenesis in a mammal by administering an antibody which specifically binds to EphriniB2 or EphB4; cardiovascular disorders |
| 12/21/2006 | US20060288432 Identification of a jak2 mutation in polycythemia vera |
| 12/21/2006 | US20060288431 Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells |
| 12/21/2006 | US20060287514 Mammalian cytokine-like polypeptide-10 |
| 12/21/2006 | US20060287513 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/21/2006 | US20060287508 Methods for stabilizing proteins |
| 12/21/2006 | US20060287506 Method for separating and concentrating biological materials using continuous-flow ultracentrifugation |
| 12/21/2006 | US20060287503 Analyzing fusion protein expression; biological screening |
| 12/21/2006 | US20060287502 C3b/C4b complement receptor-like molecules and uses thereof |
| 12/21/2006 | US20060287501 Soluble truncated polypeptides of the nogo-a protein |
| 12/21/2006 | US20060287273 Methods and reagents for inhibiting cell proliferation |
| 12/21/2006 | US20060287269 Short interfering nucleic acid hybrids and methods thereof |
| 12/21/2006 | US20060287267 Controlling gene expression; viricides |
| 12/21/2006 | US20060287266 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 12/21/2006 | US20060287264 RNAi modulation of the BCR-ABL fusion gene and uses thereof |
| 12/21/2006 | US20060287262 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 12/21/2006 | US20060287261 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 12/21/2006 | US20060287230 Compositions which can be used for regulating the activity of parkin |
| 12/21/2006 | US20060287226 Characterization of a membrane estrogen receptor |
| 12/21/2006 | US20060286656 Characterization of the I-SpomI endonuclease from fission yeast |
| 12/21/2006 | US20060286645 Polynucleotide constructs for increased lysine production |
| 12/21/2006 | US20060286641 Interferon-alpha/beta binding fusion proteins and therapeutic uses thereof |
| 12/21/2006 | US20060286640 Process for production of polypeptides |
| 12/21/2006 | US20060286639 Complementary DNAs encoding proteins with signal peptides |
| 12/21/2006 | US20060286638 Cell lines |
| 12/21/2006 | US20060286637 Using transgenic yeast as bioreactor for generation of sialylated glycoprotein |
| 12/21/2006 | US20060286636 VEGF variants |
| 12/21/2006 | US20060286635 Albumin fusion proteins |
| 12/21/2006 | US20060286634 Vector |
| 12/21/2006 | US20060286631 Method for preparating t-20 peptide by high cell density cultivation of recombinant e. coli containing t-20 peptide coding gene |
| 12/21/2006 | US20060286629 Methionine aminopeptidase enzymes; Wild-type Escherichia coli Met-AP; applying Qcyclase to the a peptide followed by purification on a cation exchange column |
| 12/21/2006 | US20060286605 Calcium biosensor polypeptides and methods of use |
| 12/21/2006 | US20060286597 Aortic carboxypeptidase-like polypeptide |
| 12/21/2006 | US20060286596 Method and apparatus for separating and purifying biopolymers |
| 12/21/2006 | US20060286593 Transforming Growth Factor Alpha HI |
| 12/21/2006 | US20060286592 Increased ability to convert 5-fluorocytosine prodrug to its toxic form |
| 12/21/2006 | US20060286584 Compositions and methods for the regulation of cell proliferation and apoptosis |
| 12/21/2006 | US20060286581 Heteroconfigurational Polynucleotides and Methods of Use |
| 12/21/2006 | US20060286577 Methods for detection of methylated DNA |
| 12/21/2006 | US20060286576 Methods and nucleic acids for the analyses of cellular proliferative disorders |